• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syncom Formulations (India) Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3544.0
  • ISIN : INE312C01025
17.97 0 (-1.21%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    17.85

  • Today’s High

    18.50

  • Open

    18.30

  • Perv Close

    18.19

  • 52W Low

    14.10

  • 52W High

    27.90

Key Indicators

  • P/E(TTM)

    34.63

  • Mar.Cap (₹Cr.)

    1,689.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    3.62

  • Debt-Equity Ratio

    -1.21

  • AGM Date

    01-Aug-2025

  • EPS

    0.52

  • P/E Ratio

    34.63

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    1,689.18

  • RONW (%)

    9.30

  • ROCE (%)

    10.91

Score Board

  • Equity (₹ in Cr.)

    94.00

  • BV (₹)

    3.60

  • Sales( ₹ in Cr.)

    462.85

  • NP (in Cr.)

    48.87

  • NP Var(%)

    112.0

  • Div%

    0.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.50

  • Traded Value (₹ in Lakhs)

    1,692.94

  • 52 Week High

    27.90

  • 52 Week Low

    14.10

  • Price BSE

    18.0

  • Price NSE

    18.00

  • Market Capital( in Cr.)

    1,692.94

  • P/C Ratio

    31.30

  • P/E Ratio

    34.60

  • Price Vs.BV

    0.50

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 258.36 224.64 219.66 244.81 205.51 186.77
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 258.36 224.64 219.66 244.81 205.51 186.77
Other Income 13.10 14.62 12.02 7.17 5.22 5.08
Stock Adjustments 2.18 -0.05 -3.32 4.05 3.70 1.01
Total Income 273.64 239.21 228.36 256.03 214.43 192.86
EXPENDITURE :            
Raw Materials 157.74 142.07 137.23 165.51 155.32 136.66
Power and Fuel Cost 6.13 5.31 4.38 3.84 3.93 3.63
Employee Cost 33.57 24.44 20.73 18.24 15.80 15.21
Other Manufacturing Expenses 2.39 3.19 2.26 2.09 2.02 1.72
Selling and Administration Expenses 29.62 27.29 29.71 19.79 13.76 16.90
Miscellaneous Expenses 3.03 2.41 2.00 1.34 1.65 1.82
Employee Benefit Expenses 33.57 24.44 20.73 18.24 15.80 15.21
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 232.47 204.71 196.32 210.81 192.47 175.94
Operating Profit 41.18 34.51 32.05 45.22 21.96 16.93
Interest 4.70 3.40 1.93 0.48 0.61 0.25
Gross Profit 36.48 31.11 30.12 44.74 21.35 16.68
Depreciation 4.72 4.54 3.95 4.03 4.06 4.00
Profit Before Tax 31.76 26.57 26.17 40.71 17.29 12.68
Current Tax 7.58 6.65 6.25 11.30 4.43 3.44
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.55 -0.15 0.14 0.23 -1.40 -1.86
Reported Net Profit 23.62 20.07 19.79 29.17 14.25 11.09
Extraordinary Items 0.55 0.14 0.03 0.10 -0.04 0.00
Adjusted Net Profit 23.07 19.93 19.76 29.07 14.29 11.09
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 79.36 62.11 42.32 13.15 11.40 7.81
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 2.82 0.00 0.00 12.50 7.50
P & L Balance carried down 102.99 79.36 62.11 42.32 13.15 11.40
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 3.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.03 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.25 0.21 0.23 0.37 0.18 0.14
Earnings Per Share(Adj)-Unit Curr 0.25 0.21 0.23 0.37 0.18 0.14
Book Value 3.05 2.72 2.52 2.25 1.87 1.70
Book Value(Adj)-Unit Curr 3.05 2.72 2.52 2.25 1.87 1.70

Shareholding Pattern

  • Promoter Group

    50.57%

  • Public Share Holding

    49.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 83,061,125 8.84 83,061,125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392,286,474 41.73 392,286,474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475,347,599 50.57 475,347,599 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,844,445 0.41 3,844,445 12
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 17,224 0.00 17,224 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,861,669 0.41 3,861,669 14
2] Non Institution
Bodies Corporate 10,386,788 1.11 10,386,788 257
Clearing Members 144,830 0.02 144,830 10
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 16,782,214 1.79 16,679,714 1,989
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 9,536,502 1.01 9,536,502 1,794
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 59,498,929 6.33 59,498,929 134
Individuals holding nominal share capital up to Rs. 1 lakh 361,897,258 38.50 359,496,578 466,854
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,544,211 0.27 2,544,211 1
Sub Total 460,790,732 49.02 458,287,552 471,039
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 940,000,000 100.00 937,496,820 471,066

Company Background

Syncom Formulations (India) LtdPharmaceuticals - Indian - Formulations

  • Syncom Formulations (India) Ltd
  • BSE Code : 3544.0
  • ISIN : INE312C01025

  • Incorporation Year

    1988

  • Registered Office

    7 Niraj Indl Estate Andheri(E)
    Off Mahakali Caves Rd, Mumbai,
    Maharashtra-400093

  • Telephone

    91-22-30887744

  • FAX

    91-22-30887755

  • Chairman

    Kedarmal Bankda

  • Managing Director

    Vijay Shankarlal Bankda

  • Company Secretary

    Vaishali Agrawal

  • Auditor

    Sanjay Mehta & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Syncom Formulations (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syncom Formul. 18.01 271.46 258.36 34.63 10.32
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10